RT
Ryvu Therapeutics SA
🇩🇪XFRA.9Y4GermanyHealthcare
€3.75EURdown -0.07 (-1.83%)OpenEnd of day1:22 PM
Price€3.75-0.07 (-1.83%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- PLSELVT00013
- CUSIP
- Not reported
Company
- Employees
- 228
- Headquarters
- Kraków, Poland
- Website
- https://ryvu.com
- CEO
- Mr. Pawel Tadeusz Przewiezlikowski M.B.A., M.Sc.
Market
- Shares outstanding
- 23.1M
- Market cap
- €86.7M
Highlights
No high and low reported for today's session.
- Market cap
- €86.7M
- EPS LTM
- -PLN 3.83
- P/E LTM
- -5.90
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- PLN 62.27M-15.04%down year on year
- Net income
- -PLN 88.6M+24.47%up year on year
- Gross margin
- -47.74%-163.79%down year on year
- Free cash flow
- -PLN 98.74M+27.55%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.